CJC-1295 + Ipamorelin – Peptide Foundry
US$ 20.64
ghk-cu peptide structure | C28H48CuN12O8 | CID 133697840 GHK-Cu 50mg | Buy Research
Description
Stereochemical modifications at key positions (e.g., C3, C20) can switch compounds between agonist, antagonist, and receptor-selective profiles, enabling targeted development of G-protein-biased ligands with minimized -arrestin-2 recruitment
doi:10.1016/j.amjoto.2021.103151
100 g/mL Nle-YI-(6) aminohexanoic amide in 10 - was used as an internal standard and added to each sample on ice
Topical is the validated route
Wang, Zhaowei
